Zota Health Care Ltd's Q3FY25 Quarter Results
- 14 Feb 2025
Result Summary
- Zota Health Care Ltd reported a 7.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 54.3%.
- Its expenses for the quarter were up by 13.2% QoQ and 82.9% YoY.
- The net profit increased 55.5% QoQ and increased 544.2% YoY.
- The earnings per share (EPS) of Zota Health Care Ltd declined at 6.3 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 72.63 | 67.82 | 47.08 | 7.1% | 54.3% |
Total Expenses | 91.11 | 80.51 | 49.82 | 13.2% | 82.9% |
Profit Before Tax | -18.48 | -12.69 | -2.73 | 45.6% | 576.9% |
Tax | 0.46 | -0.51 | 0.20 | -190.2% | 130.0% |
Profit After Tax | -18.94 | -12.18 | -2.94 | 55.5% | 544.2% |
Earnings Per Share | -6.30 | -4.20 | -1.10 | 50.0% | 472.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Zota Health Care Ltd is a company operating within the healthcare industry, primarily known for its production and distribution of pharmaceutical products. The company is involved in the development, manufacture, and marketing of a broad range of health-related products, including over-the-counter (OTC) medications and prescription drugs. As of the latest updates, the company has been focusing on expanding its product portfolio and market reach, although specific recent developments are not detailed in the provided data.
Revenue
During the third quarter of the fiscal year 2025 (Q3FY25), Zota Health Care Ltd reported a total income of ₹72.63 crores. This represents a quarter-over-quarter (QoQ) increase of 7.1% from ₹67.82 crores in Q2FY25. The year-over-year (YoY) change is even more significant, with a 54.3% increase from ₹47.08 crores in Q3FY24. These figures highlight substantial growth in revenue over both timeframes, suggesting robust sales performance in the reporting period.
Profitability
Zota Health Care Ltd's profitability metrics for Q3FY25 show a challenging scenario, with a reported profit before tax of -₹18.48 crores. This is a notable increase in loss from -₹12.69 crores in the previous quarter (Q2FY25), marking a 45.6% decline QoQ. Compared to the same quarter last year (Q3FY24), where the company had a smaller loss of -₹2.73 crores, the YoY change is a significant 576.9% increase in losses. The profit after tax also follows a similar pattern, recorded at -₹18.94 crores, representing a 55.5% QoQ decline from -₹12.18 crores and a 544.2% YoY decline from -₹2.94 crores. Earnings per share (EPS) for Q3FY25 is -₹6.30, up from -₹4.20 in Q2FY25 and -₹1.10 in Q3FY24, indicating increased losses per share over the periods.
Operating Metrics
The operating expenses for Zota Health Care Ltd in Q3FY25 amounted to ₹91.11 crores, which signifies a 13.2% increase from the previous quarter's ₹80.51 crores and an 82.9% rise from ₹49.82 crores in Q3FY24. Despite the rise in total income, the higher growth rate in expenses suggests increased operational costs. Tax expenses for the quarter were ₹0.46 crores, which contrasts with a tax credit of -₹0.51 crores in Q2FY25, marking a -190.2% change QoQ, and an increase from ₹0.20 crores in Q3FY24, reflecting a 130.0% YoY change. These trends in expenses and taxation contribute to the overall financial performance challenges observed in the profitability metrics.
